12:00 AM
 | 
Feb 28, 2011
 |  BC Week In Review  |  Clinical News  |  Regulatory

Hizentra human immune globulin regulatory update

FDA approved an sBLA from CSL to extend the shelf life of Hizentra human immune globulin...

Read the full 57 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >